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Abstract
Background: The development of reliable, high quality health-related guidelines depends on explicit and transparent 
processes, methods aimed at minimising risks of bias and the inclusion of all relevant expertise and perspectives. While 
the methodological aspects of guidelines have been a focus to improve their quality, less is known about the social 
processes involved, for example, how guideline group members interact and communicate with one another, and how 
the evidence is considered in informing recommendations. With this in in mind, we aimed to empirically examine the 
perspectives and experiences of the key participants involved in developing public health guidelines for the Australian 
National Health and Medical Research Council (NHMRC). 
Design: This study was conducted using constructivist grounded theory as described by Charmaz, which informed our 
sampling, data collection, coding and analysis of interviews with key participants involved in developing public health 
guidelines.
Setting: Australian public health guidelines commissioned by the NHMRC.
Participants: Twenty experts that were involved in Australian NHMRC public health guideline development, including 
working committee members with content topic expertise (n = 16) and members of evidence review groups responsible 
for evaluating the evidence (n = 4).
Results: Public health guideline development in Australia is a divided process. The division is driven by 3 related factors: 
the divergent disciplinary background and expertise that each group brings to the process; the methodological limitations 
of the framework, inherited from clinical medicine, that is used to assess the evidence; and barriers to communication 
between content experts and evidence reviewers around respective roles and methodological limitations.
Conclusion: Our findings suggest several improvements for a more functional and unified guideline development 
process: greater education of the working committee on the methodological process employed to evaluate evidence, 
improved communication on the role of the evidence review groups and better facilitation of the process so that the 
evidence review groups feel their contribution is valued. 
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Background
Due to the large number of organisations and governments 
that produce guidelines, end-users are often presented with 
contradictory recommendations and guidelines of varying 
quality.1,2 In order to improve the quality of guidelines, several 
organisations around the world such as the World Health 
Organization (WHO),3 the National Institute for Health and 
Care Excellence,4 and the United States Community Preventive 
Services Task Force5 have developed standards and criteria 
for their development. For example, the WHO Handbook for 
Guideline Development, 2nd Edition requires that the process 
for developing a recommendation is explicit, transparent, and 
uses methods aimed to minimise risk of bias; the guideline 
development group includes all relevant expertise and 
perspectives, and that recommendations consider benefits 
and harms as well as other relevant factors.3 Currently in 
Australia, there are standards for guidelines approved by the 
National Health and Medical Research Council (NHMRC) 
and guidance to achieve these standards is being developed.6,7 
GRADE (The Grading of Recommendations Assessment, 
Development and Evaluation) is widely endorsed as a 
methodology for clinical guideline development worldwide, 
including by the WHO and NHMRC.3 GRADE allows for 
a transparent rating of the quality of evidence and rates the 
confidence in effect estimates for benefits and harms as high, 
moderate, low, or very low.8 GRADE has been optimised for 
evaluating clinical interventions and randomised controlled 
trials.
Public health guidelines offer recommendations to 
prevent ill health or to improve the health of a population, 
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Implications for policy makers
• Improvements in the social processes of guideline development could reduce the tensions and division that have been identified between the 2 
key groups of participants involved in this study – evidence evaluators and content experts.
• More pragmatic advice and training for the working committee members unfamiliar with the methodological frameworks used to assess the 
body of evidence is necessary. 
• The evidence review groups need to feel appropriately supported in their roles when presenting the evidence reviews, particularly by the 
working group chairs. 
• There is a need to work collaboratively from the outset and throughout the duration of the guideline process, to make it more collegial, effective 
and efficient.  
• To enhance the transfer of ideas, knowledge and expertise, the physical separation that is currently present between the 2 groups should be 
reduced by integrating the groups, with subgroups to evaluate the evidence for particular questions.
Implications for the public
Public health guidelines are designed to protect the public’s health. Therefore, the methods and processes that are used to evaluate the evidence and 
formulate the recommendations need to be rigorous, transparent and free of bias. Further, the 2 groups that are responsible for developing these 
guidelines, the evidence review groups and working committees with content expertise, must also work effectively together. However, the current 
practise of these groups working separately throughout the guideline development process leads to division and conflict. The recommendations 
we have made in this study will lead to a more functional and unified guideline development process that best uses all the relevant expertise, and 
therefore may contribute to better health outcomes for the public.
Key Messages 
which are tailored to a specific audience (ie, public health 
policy-makers, healthcare providers, patients, caregivers, 
the public and other relevant stakeholders).3,9 For example, 
NHMRC guidelines assess the health harms of living near 
a windfarm10 or provide dietary advice for Australians.11 
Unlike clinical practice guidelines, the available evidence for 
the development of public health guidelines is seldom from 
randomised controlled trials but instead is often derived from 
observational studies such as cohort studies, case controls, or 
time series analyses. Further, GRADE has not been developed 
to account for all important considerations related to public 
health guideline development, for example it does not 
provide explicit guidance for when evidence is linked across 
a causal pathway.12 Depending on the risk of bias tool used, 
GRADE can also downgrade non-randomised controlled 
trial evidence, even if this is the only and most appropriate 
type of evidence available. The use of GRADE for developing 
public health guidelines or conducting systematic reviews in 
the field of public health has been previously studied.13 While 
it has been recognised as a systematic and transparent process 
of evaluating the evidence, challenges have been identified in 
its use due to the complex nature of public health exposures.
Although the most rigorous and trustworthy guidelines are 
evidence-based, evidence may not be the greatest influence 
in the formation of guidelines.14 In clinical practice guideline 
development, previous experiences and beliefs that are not 
consistent with the research evidence are prioritised when 
developing recommendations.15 Further, the status and, 
therefore, power of the guideline development groups have 
been shown to influence the level of input made by individuals 
in multidisciplinary guideline panels.16 
Several studies have examined how participants 
involved in public health guidelines translate evidence into 
recommendations. Guideline development group members 
may conceptualise the guideline development task differently, 
with some prioritising the evidence in informing their decision-
making, while others, their disciplinary expertise.17Although 
the diversity of opinions in such groups brought tensions, 
diversity was vital in making informed judgements, relevant 
to making recommendations.17,18 Tensions have also been 
experienced between guideline development groups and 
those conducting the evidence synthesis.19 
While the methodological aspects of the guideline process 
have been a focus for improving the quality of guidelines,3-5 
less is known about the guideline development groups 
social processes. We conducted a grounded theory study to 
understand the perspectives and experiences of those involved 
in the development of public health guidelines. Consistent 
with a grounded theory approach, we define social processes 
as participants’ actions, interactions, and decision-making 
within the context of a guideline development process with a 
specified beginning and endpoint.20 We aimed to understand 
the perspectives and experiences of the 2 key groups of 
participants involved in developing public health guidelines 
for the NHMRC: the evidence review groups and the working 
committees (see Table 1 for a description of these roles). We 
included these 2 groups to allow a broad understanding of the 
guideline process, to learn about the relationships these groups 
of participants have with one another, and how, if at all, these 
relationships shape the guideline process. By understanding 
these viewpoints, we aimed to gain a greater understanding 
of the social influences on the guideline development 
process, including, how guideline group members interact 
and communicate with one another, and how the evidence is 
considered in informing recommendations. Such influences 
on the guideline development process are not apparent in the 
various handbooks written on the methodological procedures 
and technical aspects of guideline development.
Methods 
This study was conducted using constructivist grounded 
theory as described by Charmaz, which informed our 
sampling, data collection, coding and analysis.20 This type 
of grounded theory asserts that the knowledge produced is 
contextually created by the participants of the research and 
by the researcher. Grounded theory was explicitly developed 
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to analyse social processes that include participants’ actions 
and interactions and how they are shaped by their diverse 
and complex experiences.20,22 We sought to learn about the 
various unseen situations, relationships and tacit networks 
in the guideline process, seeking to unearth any relationships 
of power and communication that are not captured in the 
published guideline documents.22 We remained aware of our 
professional and disciplinary expertise and kept coding and 
interpretation close to the data. 
Participants and Sampling
We selected participants that were part of the development 
of a public health guideline published from 2013 or later, or 
currently under development for the NHMRC in Australia. 
We use the term ‘guideline’ in this study to represent the 
guidelines, information papers and statements that the 
included groups produced for the NHMRC. We use the 
term ‘working committee’ in this study to represent those 
participants that were part of working committees, reference 
groups and advisory groups that reported to the Council 
of the NHMRC (Table 1).We use the term ‘evidence review 
groups’ to represent those participants that were contracted 
by NHMRC to review and evaluate the evidence for targeted 
questions that informed the development of a ‘guideline’ 
(Table 1). 
Initially we sampled purposively to seek multiple 
perspectives from those with in-depth and varied experiences 
with the guideline development process. We reasoned that 
the perspectives and opinions of the process would vary 
between guidelines and the roles that were undertaken as 
described in Table 1. We therefore invited all members of 
guideline working committees and evidence review groups 
to be part of the study. As we used constant comparative 
analysis techniques throughout the process, after our initial 
data collection and analysis, we used theoretical sampling 
to seek data that would continue to develop and refine our 
emerging theoretical concepts.20 That is, we modified our 
recruitment strategy in response to what we had heard from 
early participants in order to fill gaps in our data and to test 
and advance our developing ideas
We identified participants by emailing the NHMRC contact 
addresses for randomly selected public health guideline topics 
on the NHMRC websites and asked the NHMRC contact 
person to invite all participants that had been involved in 
the development of the guideline. We provided a participant 
information statement to share with eligible participants. If 
Table 1. Roles and Responsibilities of the Working Committeea (Verbatim Description From NHMRC Guidelines for Guidelines Website)21 and Evidence Review Group
Group Member Key Responsibilities
All members
•	 Agree on the scope, questions and P[I/E]CO
•	 Contribute constructively to meetings, including approving the minutes
•	 Declare all relevant interests so that conflicts of interest can be identified and managed
•	 Develop actionable recommendations based on reviews of evidence
•	 Identify potential implementation issues and propose steps to overcome them
•	 Assess the acceptability and feasibility of the recommendations
•	 Weigh the potential risks and benefits of treatment
•	 Make decisions on what information should be included
•	 Consider and deliberate on public consultation submissions
Chair
•	 Contribute to the drafting of terms of reference and formation of the guideline development group
•	 Facilitate group processes and promote balanced participation of group members
•	 Support effective consumer involvement
•	 Manage conflicts of interest during meetings
•	 Ensure that the group stays focused and task oriented
•	 Delegate work and co-ordinate output of the group
Content experts
•	 Apply their knowledge to improving the identification of relevant evidence
•	 Advise on how to identify best practice in areas for which limited evidence is available
•	 Identify, critically appraise and synthesise evidence into a format useful for developing recommendationsb
•	 Assist the group in understanding the evidence and evidence-to-decision processb
Consumers
•	 Consider to what extent published evidence reflects outcome measures that consumers consider important
•	 Ensure that questions and recommendations address consumer issues and concerns
•	 Ensure that the guideline is worded appropriately
Methodological 
expertsc
•	 Identify, critically appraise and synthesise evidence into a format useful for developing recommendations
•	 Assist the group in understanding the evidence and evidence-to-decision process
•	 Maintain comprehensive records
Evidence review 
groupd
•	 Conduct an independent evidence evaluation of all the relevant scientific research, using internationally recognised 
systematic review methods to perform the evidence evaluation to the highest possible standard
•	 Assist the guideline working committee to understand the evidence evaluations
Abbreviations: P[I/E]CO; Participant, Intervention/Exposure, Comparator, Outcome; NHMRC, National Health and Medical Research Council.
a In the current NHMRC Guideline for Guidelines website from which we sourced this table, the working committees we refer to are called ‘guideline development 
groups.’ However, for consistency with how they are described in our study we have called them working committees. 
b This is often considered a core task of content experts, particularly in the absence of a methodological expert. 
c There are methodologists on the working committee, but they do not complete the reviews as described here.
d Not verbatim text. We included this description for our study only.
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a guideline participant expressed interest in being involved 
in the study, we were given their contact information by the 
NHMRC. We also contacted potential participants suggested 
by colleagues or other participants that we interviewed. All 
information necessary to contact these participants was in the 
public domain. 
Data Collection
Between April 2018 to July 2018, in-depth, semi-structured 
interviews were conducted by NC face to face in the 
participant’s or our research team workplace, or over the 
telephone when participants were unavailable to meet in 
person. Both face to face and interviews conducted over the 
phone were of similar nature and length23 (39-77 minutes; 
average 57 minutes). The interview guide was designed to 
evoke the participants’ opinions and experiences in being 
involved in the guideline development process and to remain 
open to what participants’ deemed salient to the process of 
guideline development (see Table 2). The interviews were 
digitally recorded and professionally transcribed. Every 
participant in the study gave written or verbal consent and all 
were informed that they were free to withdraw from the study 
at any stage during the process.
Analysis
NC wrote field notes immediately after each interview to 
capture thoughts on the interview, participants and initial 
ideas. Transcripts were analysed as soon as they were 
received. We used initial line by line coding to inductively 
generate multiple ideas from our early interviews and data.20 
We identified a group of codes that captured the relationships 
between the various groups of participants and their views on 
the methodological challenges of the guideline development 
process.
Throughout the study NC wrote case based and conceptual 
memos, which were discussed with the authorship team 
during regular meetings.20 These memos drew on the 
emerging data and were used to write the initial codes and to 
develop our thinking on participant views about the guideline 
decision-making processes, including identifying similarities 
and difference between the various groups of guideline 
participants. This early analysis influenced questions for 
future interviews, as we sought to test emerging concepts 
from the data and refine our developing ideas. 
Reflexivity
The authors bring different expertise and methodological 
perspectives to this study; LB is primarily a quantitative 
researcher and has served on a number of public health 
and clinical health guideline panels; QG and LP are health 
professionals with experience in advanced qualitative 
methods and public health practice, and NC is a doctoral 
student receiving training in quantitative and qualitative 
methods. This diversity of perspectives, but connection to the 
guideline community, means we aimed to offer a constructive 
critique to improve the methods of guideline development.
Results
We approached 36 potential participants via email and 
interviewed 20 (10 male and 10 female). Thirteen people did 
not respond to emails and 3 could not commit to a time. We 
had a lower response rate from individuals in evidence review 
groups. We interviewed 16 working committee members, and 
4 evidence review group members. By interview 16, similar 
narratives were shared. We recruited 4 additional participants 
representing diverse perspectives to ensure exploration of the 
range of experiences and determined saturation at interview 
20.20 
The experiences of the guideline development process 
were markedly different for the 2 key groups of participants 
involved in the process, the evidence review groups and the 
working committees. These experiences suggest that public 
health guideline development in Australia is a divided process. 
The division is driven by 3 related factors: the divergent 
disciplinary background and expertise that each group 
brings to the process; the methodological limitations of the 
framework, inherited from clinical medicine, that is used to 
assess the evidence; and barriers to communication between 
content experts and evidence reviewers around respective 
roles and methodological limitations.
Divergent Disciplines 
Participants on the working committees had divergent 
disciplinary backgrounds (eg, physicians, toxicologists, 
clinical and public health researchers) compared to those 
on evidence review groups (eg, systematic review experts) 
and held varying, sometimes conflicting beliefs about what 
constituted ‘good’ evidence. Many experts on the working 
committee viewed their primary role as protecting the 
Table 2. Interview Guide
Question Prompt
Tell me a little about your role in the 
guideline development? Specific responsibilities? Level of responsibility? Level of input?
Tell me about the guideline 
development process?
How was evidence defined? How was the evidence summarised? How was the quality of the evidence assessed, 
if at all? How was evidence synthesised? What other factors contributed to rating the quality of the overall body 
of evidence? What factors (other than the evidence reviewed) contributed to the rating of recommendations?
If any, what do you feel were the key 
challenges in the process?
What was done in the absence of evidence?  Were there challenges in assessing the risks of bias or quality of the 
evidence?  Was a formal method applied for rating recommendations eg, GRADE? If so, what worked or did not 
work about this method?
What else should I know about the 
process? Stakeholder input? Relationships between various experts? Lack of standardised criteria?
Abbreviation: GRADE; Grading of Recommendations Assessment, Development and Evaluation.
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public’s health through reducing possible harms to hazardous 
exposures or recommending interventions that would 
improve health outcomes. These individuals often viewed 
‘good’ or ‘important’ evidence from the perspective of their 
own knowledge and expertise and not from the standards of 
methodological rigour used by the evidence review groups.
For example, one working committee member often felt that 
studies with statistically significant harms or benefits should 
be included in the body of evidence to form recommendations, 
even if they had been excluded by the evidence review groups 
on methodological grounds.
“There was a critical study which, you know, some of the older 
studies were omitted because they were methodologically not 
considered acceptable; but, they were strong results, so it was 
thought they couldn’t be dismissed” (participant #18, working 
committee member).
The evidence review groups, however, were contracted 
to evaluate the evidence using explicit methodological 
frameworks, such as systematic reviews and GRADE, that had 
very clear criteria for how the evidence was to be evaluated. 
The evidence review groups were aware of these disciplinary 
backgrounds and beliefs that the working committees brought 
to the guideline development and recognised the importance 
of having these experts involved in the process. However, they 
were also aware of the challenges that this presented because 
the evidence known and used by experts often did not meet 
the necessary criteria for inclusion. 
“…So you want experts, sure and of course a lot of these 
experts, they’re very professional and they produce really good 
research and of course they’re attached to that research … 
My experience has been a common thing when you first 
present the evidence review or the systematic reviews you’ve 
done, they get upset because it’s not what they know and it’s 
different – it’s looked through a different lens” (participant 
#19, evidence review group member).
These divergent roles and epistemological beliefs led to 
conflict and division between the groups. Many of the working 
committee members believed that in order to best protect the 
public’s health, the evidence presented by the review groups 
should at times be challenged. 
“Yeah, it wasn’t all plain sailing, there were differences 
of opinion, yep, and there were differences of opinion on 
what should be included, because some of the people on the 
committee were experts in their field and had contributed to 
the literature, so that makes it also that little bit different” 
(participant #6, working committee member chair). 
The evidence reviews groups however, saw this process as 
being hostile, aggressive and at times they felt victimised for 
doing their job. They felt that the evidence-review role they 
had been contracted to complete was not respected by some 
working committee members. 
“We’re trying to do the best we can, we’re not content 
experts, we’re methodology experts, you know, we’re not 
deliberately trying to sabotage the process, we’ve got to work 
with people, but it always seems to come back to what feels 
like a very personal attack … it often is quite aggressive” 
(participant #10, evidence review group member).
For at least some participants, the guideline development 
process was a divided one, with one dominant group offering 
content expertise and the other group attempting to provide 
methodological expertise. 
 Methodological Limitations 
It was widely considered by all participants that the evidence 
reviews, and guideline development processes should be 
rigorous and transparent and that this would enhance the 
credibility of the guidelines.
“I think that’s NHMRCs main goal of this whole process is 
that it would be as transparent and reproducible as possible 
that every decision is documented, and process driven 
as much as possible but there’s a framework for each step, 
and I think that’s working reasonably well” (participant #4, 
working committee member).
Although working committee members were generally 
supportive of the processes they used, they acknowledged 
methodological limitations. For example, several working 
committee members recognised that the methods used in 
evaluating the evidence for their public health guideline 
topic were designed for clinical medicine and evaluation of 
randomised controlled trials.
“The problem is that NHMRC holds you to their standards 
of evidence, which are designed for other forms of evidence. 
They’re designed mainly in the medical domain and drug 
domain. So, to apply them to something like (topic) is 
ridiculous” (participant #12, working committee member).
They described how relevant and important evidence was 
consistently being downgraded, leading to a body of evidence 
used that appeared low quality.
“So, because it was this public health type evidence, what 
it meant was that none of the gradings were very high. And 
that we thought that – and I think many people have had 
the same views – that it was really not appropriate. And that 
the randomised clinical trial approach to evidence obviously 
a gold standard and so on, but that it was important not 
to throw out all the other things where – where randomised 
clinical trials were never going to be possible” (participant 
#7, working committee chair).
When following GRADE guidance, little or no evidence 
leads to recommendations that are rated as “weak.” Several 
working committee participants and chairs were concerned 
that weak recommendations would not be understood by 
policy-makers in determining appropriate action to protect 
the public’s health or would be misrepresented by industries 
that may wish to discredit their findings.
“But we had to, and we argued a lot about how to word 
this exactly, because if you say there’s no evidence it could 
mean that there just isn’t enough research to know or there 
is evidence that it doesn’t cause that. So we had to be very 
careful with the wording…So I remember we argued, and 
argued and argued about the wording of that to get it to a 
situation that we were all happy with” (participant #16, 
working committee member).
However, the evidence reviews groups often felt that they, 
and not the methodological frameworks, were blamed for the 
way the evidence was evaluated.
“I mean, that’s essentially what we did but it’s a very 
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uncomfortable position to be in. I feel like they like the idea 
of it. But in practise when you give the results their sort of 
like, they’re shocked, and I mean, the methods can only do 
so much and they’re not flawless, there’s limitations they just 
don’t often expect what they get at the end” (participant #1, 
evidence review group member).
Despite such criticism, the evidence review groups’ members 
who had intimate knowledge of the methodological process 
and were aware of how the evidence would be presented, 
understood why the working committee were frustrated, and 
were even empathetic to these issues as they knew what the 
limitations of the framework were.
“I don’t mean to be critical of the working group or the 
NHMRC and I think this was very challenging right from 
the beginning because it’s public health intervention and a 
good example of using the GRADE process. It’s very difficult 
because they’re all observational studies…and there were 
quite a lot of issues” (participant #19, evidence review 
group member).
Barriers to Communication 
The evidence review groups contracted by the NHMRC 
worked independently from the working committee for most 
of the process. Evidence Review group members were unable 
to share with the working committee insights and opinions on 
the best approach to identifying or evaluating the evidence. 
Further, the 2 groups were unable to help one another to 
understand each other’s point of view. The transfer of ideas, 
knowledge and expertise was limited by the separation of the 
2 groups.
“No, no, that’s actually a challenge too, because they 
decided to outsource them to a body that has expertise in 
doing systematic reviews, but not topic specific expertise” 
(participant #5, working committee chair).
Not including content experts in the evidence review 
process provided the opportunity for working committees to 
be critical of the evaluations of the evidence review groups. 
For example, the content experts felt that the evidence review 
experts lacked the necessary knowledge on a guideline topic 
to identify all the relevant literature necessary to inform the 
guideline. 
While conversely, the complexity of the methodology 
meant that unless working committee members had a 
methodological background, they found it difficult to 
understand and follow the evidence evaluations, when they 
were presented by the evidence review groups. 
“So, they would, we’d have these 2-day meetings and 
the people who run the tender to do the systematic review 
would kind of explain the methodology and, I’m not a 
methodologist so a lot of it went past me, about what you 
should include and what kind of grade recommendations 
could be supported, by what kind of evidence and so forth” 
(participant #16, working committee member).
This highlights how by not working with the evidence 
review groups regularly from the outset and understanding 
the methods thoroughly, some working committee members 
felt limited in their ability to contribute to the guideline 
process due to their lack of methodological knowledge and 
training.
This separation between the groups was also seen by the 
evidence review groups as a major limitation in how the 
guideline process was conducted. The irregularity of the 
meetings at which the evidence reviews groups presented 
their findings to the working committees meant it became an 
ineffective way of communicating with the working committee 
on how the evidence was being evaluated with the methodology 
employed.
“Here it would include the GRADE process, and everyone 
goes yeah, okay, we understand that, that’s good, but when 
it comes to the presentation it’s usually so long after they’ve 
forgotten – even for us it’s challenging” (participant #19, 
evidence review group member). 
As a result of this, when evidence review groups did advise 
the working committee on what evidence should or should 
not be included, they were criticised for their suggestions.
“I don’t know. What we were told is don’t tell us what to 
do, which shook us quite a bit because we were like well, we’re 
just giving advice. Like, we don’t mind if you don’t take it 
but this is a wee bit challenging. So, then you don’t know 
what your role is” (participant #19, evidence review group 
member).
The evidence reviews groups felt that this criticism from 
the working committees grew from the separation of duties, 
and failure to have effective communication strategies in 
place. The evidence review groups members felt that many 
of the tensions that were experienced between groups of 
participants could have been limited if working committees 
were provided with clear information about the different roles 
of the 2 groups.
“But certainly for these 2 NHMRC ones it felt combative 
and I don’t – and it’s been an unpleasant process for us and 
we’ve felt that either the Chair should stand up and just – 
it’s just little things, like just saying, you know, if someone’s 
attacking the work, just stop in and say, look, these guys have 
done and spent a lot of time and a lot of work on this so let’s 
just calm down and let them talk through the methodology 
of how they’ve done it” (participant #10, evidence review 
group member). 
Throughout the process evidence review groups felt a 
lack of support when delivering their work that was at times 
confronting and difficult for some working committee 
members to accept. Evidence review groups recognised an 
unequal and unfair power dynamic between the 2 groups. 
This led to the evidence review group members feeling 
that they were not valued or respected contributors to the 
guideline process.
“But it’s my experience in working with these advisory 
committees, particularly with the NHMRC that it’s the 
committee that makes the decision and the evaluation group 
is very much, you know, in a responsive position and pretty 
much on the back foot” (participant #10, evidence review 
group member). 
While the roles and responsibilities of these 2 groups in 
the guideline process may not be intended to be equal, it is 
highlighted here that the evidence review groups felt that 
they played a passive role. Being in a ‘responsive position’ 
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demonstrates how this division is perceived by the evidence 
review groups as a process that is dominated by a working 
committee that do not fully value their contribution to the 
guideline process. 
Discussion
The methods experts and content area experts interviewed 
for our study agree that rigorous methods should be used 
to develop public health guidelines that are considered valid 
and trustworthy. Our findings suggest that more attention 
needs to be given to the social processes influencing guideline 
development in order for the experts to achieve this shared 
goal. The division that is present in public health guideline 
development in Australia is driven by the divergent disciplines 
the 2 key groups of participants bring to the process, the 
methodological limitations of the framework that is used to 
assess the body of evidence, and the inadequate integration 
and clarity of the respective roles of the evidence review and 
working committees. These divisions were emphasised by 
the lack of interaction between the groups. These themes are 
echoed in the literature exploring the experiences of different 
guideline working committees using similar methodological 
approaches.18,19 Our study however, extends this prior 
research by not only understanding the experiences of the 
working committees, but also giving a voice to members of 
the evidence reviews groups to understand the experience 
from their perspective, and the social processes involved in 
public health guideline development.
Strengths and Limitations
This is the first comprehensive empirical investigation, to 
the best of our knowledge, into the process of public health 
guideline development in Australia. This study included 
several guideline topics and participants from diverse 
backgrounds thus allowing us to analyse the experience of 
different groups of participants involved in the process. 
This work reflects the opinions and experiences of the 
participants involved in the development of a sample of 
guidelines, and therefore it is possible that the experiences 
represented here may be different to those who did not 
participate. However, we sought to minimise this bias by 
including a diverse range of guideline topics. Four fifths of 
the respondents were working committee members, while 
only one fifth from the evidence review groups. While we 
attempted to contact more members of the evidence review 
groups, their response rate was lower and evidence review 
groups tend to have about half the number of members as 
working committees. The reason for this low response rate 
may be due to the evidence review groups being contracted 
by the NHMRC to conduct the evidence reviews and they 
therefore may feel conflicted in contributing as they are 
paid by the developer. Alternatively, they may have felt 
uncomfortable with sharing their thoughts and insights on 
the guidelines process as these experiences revealed in this 
study were often challenging. Future research should aim to 
understand these experiences further. 
We feel, however, the concepts we represent here were 
expressed by both groups as we continued our sampling and 
analysis until we reached thematic saturation.20,24 
Our Results in Relation to Other Studies
The prioritisation of disciplinary expertise that working 
committee members may have over the methodological 
expertise typical of the evidence review groups, is consistent 
with previous studies that have examined how evidence is 
conceptualised and used in forming recommendations in 
public health guidelines.17 A previous qualitative study that 
explored the social processes of how evidence is understood 
and used by guideline advisory groups found that different 
group members prioritised the ‘scientific’ evidence, such as 
randomised controlled trials in informing their decision-
making, while others their professional experiences.17 Clinical 
and practical experiences have also been shown to take 
precedence over the evidence in forming recommendations 
when using the GRADE process in the developing WHO 
guidelines that included public health topics.18 Our study 
expands on these studies by showing that the content 
and evidence review experts have differences in valuing 
randomised, clinical trials vs. clinical expertise and in how 
they value observational design studies needed for public 
health guideline development. 
The specific methodological challenges involved with 
evaluating the evidence used in public health guideline 
development described by the participants in this study 
have previously been identified in a study that explored 
the experiences of groups that have applied GRADE for 
developing guidelines or systematic reviews in the field of 
public health.13 The difficulties identified included, which 
studies to include or exclude, the inability to upgrade the 
quality of evidence from observational studies higher and 
concerns that policy-makers may potentially misinterpret 
no or low quality evidence when determining what course 
of action to take. Further, the limited understanding of 
the GRADE process used to evaluate the evidence by the 
working committee discussed in our present study, was also 
demonstrated with previous investigations into the guideline 
development process by WHO guideline groups.18,19 
The tensions felt by the evidence review groups with the 
working committee members in this present study has also 
been shown in a previous study that explored the experiences 
of methodologists working on WHO guidelines with 
discordant recommendations.19 Although methodologists 
were also part of the working committee in our current study, 
the evidence review groups were responsible for conducting 
and presenting the results of the initial evaluation and grading 
of the evidence, which makes their experiences similar to this 
previous investigation. Therefore, the experiences of feeling 
tension with the working committee members, the need for 
their role to be clearly articulated and the need to receive 
greater support from the NHMRC throughout the process, 
are relevant and consistent with these previous findings.19
Implications for Practice, Policy and Research 
Bridging the Gap in the Divided Process 
While there are methodological challenges and considerations 
that go beyond the scope of this paper,12 a number of steps could 
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be put into place to help optimise the public health guideline 
development process in Australia and globally. Improvements 
in the social processes of guideline development could reduce 
the tensions and division that have been identified between 
the 2 key groups of participants involved in this study. Firstly, 
more pragmatic advice and training by the NHMRC for the 
working committee members unfamiliar with the frameworks 
used to assess the body of evidence is necessary, not only at 
the commencement of the process but should be ongoing 
thereafter. Both the working committee and evidence review 
groups viewed understanding the methods as a significant 
challenge to the current process. Inadequate understanding 
of the methods restricts the level of input certain working 
committee members can have in the process and creates 
tensions between the groups.13,18,19 
Secondly, the role of the evidence review groups needs to be 
clearly articulated from the start and reinforced throughout 
guideline development process.19 The evidence review 
groups also need to feel appropriately supported in their 
roles when presenting the evidence reviews, particularly by 
the working groups chairs. Therefore, the power imbalances 
created between the 2 groups must be minimised through 
strong facilitation, which would allow for the evidence review 
groups to feel their contribution is respected and valued 
and their opinions heard throughout the process. These 
power imbalances could also potentially be minimised by 
paying attention to differences in age, experience, gender, 
or region between the evidence review groups and working 
committees.25
Finally, there is a need to work collaboratively from the 
outset and throughout the duration of the guideline process, 
to make it more collegial, effective and efficient. To enhance 
the transfer of ideas, knowledge and expertise, the physical 
separation that is currently present between the 2 groups 
should be reduced. While there may be benefits to keeping 
expert opinion influence away from the evidence review 
process, the infrequent meetings and lack of communication 
between the groups appears to be a significant factor in 
tensions that are made apparent when the evidence review 
groups present their findings to the working committees.25,26 
By integrating the groups, with subgroups to evaluate the 
evidence for particular questions, the tensions identified from 
this lack of contact and communication will be significantly 
reduced. Furthermore, methodologists who are members 
of the working committees could facilitate discussions of 
the reviews presented by the evidence review groups. Their 
understanding of the challenges associated with evidence 
review for public health questions could bridge a gap in 
communication between the working committees and 
evidence review groups. 
Through greater education of the working committee on 
the methodological process employed to evaluate evidence, 
improved communication on the role the evidence review 
groups play, along with better facilitation of the process so that 
the evidence review groups feel their contribution is respected 
and valued, an enhanced transfer of ideas, knowledge and 
expertise in the guideline development process will be 
possible.
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